BD Diagnostics Launches the BD Protect(TM) Infection Surveillance and Prevention Software Portfolio
Surveillance System Generates Real-time Information Designed to Reduce Spread of Infections
BALTIMORE, March 18 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today the launch of the BD Protect™ Infection Surveillance and Data Management System, a portfolio of healthcare management software solutions that tracks infections and helps prevent their transmission at three levels -- from patient to patient, between patients and healthcare workers, and from community sources to healthcare settings.
“This strategic expansion of BD’s portfolio enables us to provide a set of integrated information solutions to clinicians striving to reduce the incidence and transmission of infections in their facilities,” said Philippe Jacon, President of BD Diagnostics – Diagnostic Systems. "It is a natural complement to our rapid molecular and chromogenic assays for detection and diagnosis of these infectious organisms."
"Preventing the spread of infections is becoming more challenging each day," said Tracy Gustafson, M.D., Worldwide Director, Infection Prevention Software Development and Medical Affairs, BD Diagnostics – Diagnostic Systems. "The problem is magnified by global travel, new and more dangerous microbes, overuse and misuse of antibiotics, healthcare staffing cuts, and risks to immuno-compromised patients. The BD Protect system provides actionable information that assists infection prevention professionals in making timely decisions."
The Centers for Disease Control and Prevention (CDC) has identified healthcare-associated infections (HAIs) as one of the top 10 causes of death in the United States.(1) Designed by CDC-trained epidemiologists, the BD Protect system addresses multiple issues confronting healthcare administrators and public health officers, including the transmission of multidrug-resistant organisms in healthcare settings and escalating costs related to HAIs.
The portfolio includes three modules. BD Protect™ Infection Prevention targets reduction of HAIs in patients. BD Protect™ Healthcare Worker Safety monitors employee vaccinations, testing, in-service education, injuries and illnesses to protect both employees and patients.
BD Protect™ Syndromic Surveillance continuously analyzes emergency department patient data for reportable diseases and symptoms that could signal a possible community outbreak. It also can be used at a Health Department to collect and analyze community-wide data from multiple hospitals.
With assistance from the complete BD Protect portfolio, infection preventionists can identify, control and help prevent infections in patients, employees and the community. The software also analyzes length of stay, isolation days and infection costs and supports antibiotic stewardship, enabling hospitals to reduce expenses while providing better patient care. The BD Protect system is available in single-facility and enterprise-wide editions. Visit www.bd.com/ds/BDProtect for more information.
About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
(1) Centers for Disease Control and Prevention. (2009, July, 16). Healthcare-associated infections. Retrieved March 10, 2010 from http://www.cdc.gov/ncidod/dhqp/healthdis.html
Contact: Barbara Kalavik |
|
BD Public Relations |
|
(201) 847-4209 |
|
SOURCE BD (Becton, Dickinson and Company)
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article